Medical Patent News

RSS

Pfizer receives $2.15 billion settlement from Teva and Sun for patent-infringement damages

Pfizer Inc. announced today a $2.15 billion settlement reached with Teva Pharmaceuticals Industries, Limited and Sun Pharmaceutical Industries, Limited for patent-infringement damages resulting from their "at-risk" launches of generic Protonix® in the United States.

15 Jun 2013

Supreme Court DNA ruling leaves questions unanswered

Editorial boards weigh in on what Thursday's Supreme Court ruling means for medical research and for the medical industry.

15 Jun 2013

First Edition: June 14, 2013

Today's headlines includes reports about how, after months of battle, Arizona lawmakers endorsed a Medicaid expansion plan backed by Gov. Jan Brewer.

14 Jun 2013

Supreme Court invalidates patents held by Myriad Genetics

The College of American Pathologists applauds today's unanimous Supreme Court decision invalidating the patents held by Myriad Genetics on the BRCA1 and BRCA2 genes. It is a victory for patients and for science.

14 Jun 2013

Puritan granted European patents for high-performance PurFlock Ultra and HydraFlock swabs

Puritan Medical Products, North America's largest manufacturer of single-use specimen collection devices, announced today that it has been granted two new European patents for its high-performance PurFlock® Ultra and HydraFlock® swabs.

12 Jun 2013

Actavis files ANDA to market Propofol Injection

Actavis, Inc. today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Propofol Injection 10mg/mL.

7 Jun 2013

OxThera granted Japanese patents for treating oxalate-related disease

OxThera AB has been granted three Japanese patents during 2012 and 2013. The patents will secure the pharmaceutical composition and the method for treating and preventing oxalate-related disease with micro-organisms and enzymes and will further strengthen the Company's patent estate for this unmet medical need.

4 Jun 2013

Shire resolves patent infringement lawsuit against Teva relating to INTUNIV tablet

Shire LLC has settled its litigation against Teva Pharmaceuticals USA Inc. ("Teva") in connection with Teva's Abbreviated New Drug Application ("ANDA") for a generic version of Shire's INTUNIV (guanfacince) Extended Release Tablets for the treatment of Attention Deficit Hyperactivity Disorder.

3 Jun 2013

Patented nicotinamide riboside launched by Chromadex

ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, announced today the launch of NIAGEN, its novel, patented, branded nicotinamide riboside.

29 May 2013

Zecotek welcomes Markman hearing for infringement of LFS scintillation crystal patent

Zecotek Photonics Inc., a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the claim construction hearing, also called a Markman hearing, for Zecotek Imaging Systems Pte Ltd.'s legal action against defendants Saint-Gobain Corporation and Philips will be held on July 2, 2013, before U.S. District Judge Sara Lioi .

28 May 2013

IMRIS receives US patent for SYMBIS Surgical System

IMRIS Inc. today announced the allowance of a US patent defining the foundational technologies for its SYMBIS Surgical System - a minimally invasive and MRI-compatible microsurgical robot system.

23 May 2013

Expiring patents drive drug spending's first time fall

Patient spending on prescription drugs fell in 2012 -- for the first time ever, a new study reports -- due in part to expiring patents on brand-name drugs.

10 May 2013

European Patent Office issues notice of intent to grant patent for Nuvo Research's PENNSAID 2%

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain today announced that the European Patent Office has issued a notice of Intention to Grant a European Patent that provides protection for the Company's PENNSAID 2% product.

9 May 2013

IDIBELL signs patent licensing agreement with Minoryx

The Bellvittge Biomedical Research Institute has signed a licensing agreement with the Spanish biotechnology company Minoryx of a patent for the treatment of X-linked adrenoleukodystrophy, a rare serious neurodegenerative disease which has no effective treatment.

8 May 2013

Entremed reports patent issuance for its lead drug candidate ENMD-2076

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of a variety of cancers, today announced the issuance by the Chinese State Intellectual Property Office of Patent Certificate No. ZL 200680044656.7.

7 May 2013

EntreMed announces issuance of patent for clinical-stage compound, 2-methoxyestradiol

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of a variety of cancers, announced the issuance of a U.S. patent covering methods of treatment and formulations for its clinical-stage compound, 2-methoxyestradiol.

3 May 2013

Absorption Pharmaceuticals to obtain patent for Promescent medication

Absorption Pharmaceuticals announced today that the U.S. Patent and Trademark Office has indicated that it will grant a patent related to the use of its topical medication, Promescent, for premature ejaculation.

29 Apr 2013

HHS global health official discusses tobacco-, drug patent-related trade negotiations

Inside U.S. Trade features an interview with HHS Assistant Secretary forAffairs Nils Daulaire, who discusses how "the department is playing a larger role than ever before in the development of U.S. trade policy, including on sensitive issues in the Trans-Pacific Partnership (TPP) negotiations like a draft proposal for a tobacco-specific 'safe harbor' and the U.S. stance on issues related to intellectual property protections for pharmaceuticals," according to the publication.

25 Apr 2013

South Africa aims to close drug patent loophole that allows for 'ever-greening'

"South Africa plans to overhaul its intellectual property laws to improve access to cheaper medicines by making it harder for pharmaceutical firms to register and roll-over patents for drugs, a senior official said on Monday," Reuters reports.

24 Apr 2013

Catheter Connections receives another patent for IV disinfection technology

Catheter Connections, a start-up company co-founded by nurses seeking to reduce deadly hospital-acquired bloodstream infections, announced today the issuance of U.S. Patent Number 8,419,713, titled "Carrier Assembly With Caps for Medical Connectors."

18 Apr 2013